Negative role of trihydrophobin 1 in breast cancer growth and migration

Cancer Science

Volumn 101, Issue 10, 2010, Pages 2156-2162

  Zou, Weiying ^a   Yang, Yanzhong ^a   Wu, Yihong ^a   Sun, Linlin ^a   Chi, Yayun ^a   Wu, Weibin ^a   Yun, Xiaojing ^a   Xie, Jianhui ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; ELONGATION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21; TRIHYDROPHOBIN 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; NEGATIVE ELONGATION FACTOR; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BREAST TUMOR; CELL CYCLE; CELL MOTION; ENDOTHELIUM CELL; FEMALE; MESODERM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MESODERM; TRANSCRIPTION FACTORS;

EID: 77957028036     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01656.x     Document Type: Article

References (39)

1. Hari KL, Santerre A, Sekelsky JJ, McKim KS, Boyd JB, Hawley RS. The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell 1995, 82:815-21.
2. Bonthron DT, Hayward BE, Moran V, Strain L. Characterization of TH1 and CTSZ, two non-imprinted genes downstream of GNAS1 in chromosome 20q13. Hum Genet 2000, 107:165-75.
3. Narita T, Yamaguchi Y, Yano K. Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Mol Cell Biol 2003, 23:1863-73.
4. Yamaguchi Y, Takagi T, Wada T. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 1999, 97:41-51.
5. Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol 2001, 155:911-21.
6. Aiyar SE, Sun JL, Blair AL. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev 2004, 18:2134-46.
7. Guan X, Liu J, Ding F, Gu J, Gu X. Expression and distribution of trihydrophobin 1 in postnatal developing mouse testis. Mol Cell Biochem 2006, 292:179-87.
8. Yang Y, Zou W, Kong X. Trihydrophobin 1 attenuates androgen signal transduction through promoting androgen receptor degradation. J Cell Biochem 2009, 10.1002/jcb.22484, doi
9. Yin XL, Chen S, Gu JX. Identification of TH1 as an interaction partner of A-Raf kinase. Mol Cell Biochem 2002, 231:69-74.
10. Liu W, Shen X, Yang Y. Trihydrophobin 1 is a new negative regulator of A-Raf kinase. J Biol Chem 2004, 279:10167-75.
11. Cheng C, Kong X, Wang H. Trihydrophobin 1 interacts with PAK1 and regulates ERK/MAPK activation and cell migration. J Biol Chem 2009, 284:8786-96.
12. Miyoshi K, Rosner A, Nozawa M. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 2002, 21:5548-56.
13. Naito AT, Akazawa H, Takano H. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ Res 2005, 97:144-51.
14. Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 2007, 39:2153-60.
15. Lu J, Guo H, Treekitkarnmongkol W. 14-3-3zeta cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell 2009, 16:195-207.
16. Lopez D, Niu G, Huber P, Carter WB. Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter. Arch Biochem Biophys 2009, 482:77-82.
17. Sun J, Watkins G, Blair AL. Deregulation of cofactor of BRCA1 expression in breast cancer cells. J Cell Biochem 2008, 103:1798-807.
18. Yang Y, Liu W, Zou W. Ubiquitin-dependent proteolysis of trihydrophobin 1 (TH1) by the human papilloma virus E6-associated protein (E6-AP). J Cell Biochem 2007, 101:167-80.
19. Motokura T, Arnold A. Cyclin D and oncogenesis. Curr Opin Genet Dev 1993, 3:5-10.
20. Pines J. Cyclins: wheels within wheels. Cell Growth Differ 1991, 2:305-10.
21. Niculescu AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998, 18:629-43.
22. Cai K, Dynlacht BD. Activity and nature of p21(WAF1) complexes during the cell cycle. Proc Natl Acad Sci USA 1998, 95:12254-9.
23. Stein JP, Ginsberg DA, Grossfeld GD. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst 1998, 90:1072-9.
24. Parker SB, Eichele G, Zhang P. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995, 267:1024-7.
25. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 1997, 17:5598-611.
26. Shtutman M, Zhurinsky J, Simcha I. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999, 96:5522-7.
27. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-72.
28. Sells MA, Boyd JT, Chernoff J. p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. J Cell Biol 1999, 145:837-49.
29. Wu WS, Wu JR, Hu CT. Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species. Cancer Metastasis Rev 2008, 27:303-14.
30. Vial E, Sahai E, Marshall CJ. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4:67-79.
31. Hunger-Glaser I, Salazar EP, Sinnett-Smith J, Rozengurt E. Bombesin, lysophosphatidic acid, and epidermal growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-910: requirement for ERK activation. J Biol Chem 2003, 278:22631-43.
32. Nadja E, Detmar M. Tumor and lymph node lymphangiogenesis-impact on cancer metastasis. J Leukocyte Biol 2006, 80:691-6.
33. Gumireddy K, Sun F, Klein-Szanto AJ. In vivo selection for metastasis promoting genes in the mouse. Proc Natl Acad Sci USA 2007, 104:6696-701.
34. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-58.
35. Beavon IR. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 2000, 36:1607-20.
36. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994, 127:2021-36.
37. Doehn U, Hauge C, Frank SR. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol Cell 2009, 35:511-22.
38. Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO. Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Oncogene 2008, 27:5988-6001.
39. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-54.